Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1β

Zhonglin Xie, Mahipal Singh, Krishna Singh

Journal of Biological Chemistry · 2004 · 142 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

Matrix metalloproteinases (MMPs), a family of endoproteinases, are implicated in cardiac remodeling. Interleukin-1β (IL-1β), which is increased in the heart following myocardial infarction, increases expression and activity of MMP-2 (gelatinase A) and -9 (gelatinase B) in cardiac fibroblasts. Previously, we have shown that IL-1β activates ERK1/2, JNKs, and protein kinase C (PKC). However, signaling pathways involved in the regulation of MMP-2 and -9 expression and activity are not yet well understood. Using adult rat cardiac fibroblasts, we show that inhibition of ERK1/2 and JNKs inhibits IL-1β-stimulated increases in MMP-9, not MMP-2, expression and activity. Chelerythrine, an inhibitor of PKC, inhibited activation of ERK1/2 and JNKs and expression and activity of both MMPs. Selective inhibition of PKC-α/β1 using Gö6976 inhibited JNKs activation and the expression and activity of MMP-9, not MMP-2. Inhibition of PKC-θ and PKC-ζ using pseudosubstrates inhibited IL-1β-stimulated activation of ERK1/2 and JNKs and the expression and activity of MMP-2 and -9. Inhibition of PKC-ϵ had no effect. IL-1β activated NF-κB pathway as measured by increased phosphorylation of IKKα/β and IκB-α. Inhibition of ERK1/2, JNKs, and PKC-α/β1 had no effect on NF-κB activation, whereas inhibition of PKC-θ and PKC-ζ inhibited IL-1β-stimulated activation of NF-κB. SN50, NF-κB inhibitor peptide, inhibited IL-1β-stimulated increases in MMP-2 and -9 expression and activity. These observations suggest that 1) activation of ERK1/2 and JNKs plays a critical role in the regulation of MMP-9, not MMP-2, expression and activity; 2) PKC-α/β1 act upstream of JNKs, not ERK1/2; 3) PKC-ζ and -θ, not PKC-ϵ, act upstream of JNKs, ERK1/2, and NF-κB; and 4) activation of NF-κB stimulates expression and activity of MMP-2 and -9. Matrix metalloproteinases (MMPs), a family of endoproteinases, are implicated in cardiac remodeling. Interleukin-1β (IL-1β), which is increased in the heart following myocardial infarction, increases expression and activity of MMP-2 (gelatinase A) and -9 (gelatinase B) in cardiac fibroblasts. Previously, we have shown that IL-1β activates ERK1/2, JNKs, and protein kinase C (PKC). However, signaling pathways involved in the regulation of MMP-2 and -9 expression and activity are not yet well understood. Using adult rat cardiac fibroblasts, we show that inhibition of ERK1/2 and JNKs inhibits IL-1β-stimulated increases in MMP-9, not MMP-2, expression and activity. Chelerythrine, an inhibitor of PKC, inhibited activation of ERK1/2 and JNKs and expression and activity of both MMPs. Selective inhibition of PKC-α/β1 using Gö6976 inhibited JNKs activation and the expression and activity of MMP-9, not MMP-2. Inhibition of PKC-θ and PKC-ζ using pseudosubstrates inhibited IL-1β-stimulated activation of ERK1/2 and JNKs and the expression and activity of MMP-2 and -9. Inhibition of PKC-ϵ had no effect. IL-1β activated NF-κB pathway as measured by increased phosphorylation of IKKα/β and IκB-α. Inhibition of ERK1/2, JNKs, and PKC-α/β1 had no effect on NF-κB activation, whereas inhibition of PKC-θ and PKC-ζ inhibited IL-1β-stimulated activation of NF-κB. SN50, NF-κB inhibitor peptide, inhibited IL-1β-stimulated increases in MMP-2 and -9 expression and activity. These observations suggest that 1) activation of ERK1/2 and JNKs plays a critical role in the regulation of MMP-9, not MMP-2, expression and activity; 2) PKC-α/β1 act upstream of JNKs, not ERK1/2; 3) PKC-ζ and -θ, not PKC-ϵ, act upstream of JNKs, ERK1/2, and NF-κB; and 4) activation of NF-κB stimulates expression and activity of MMP-2 and -9. Matrix metalloproteinases (MMPs), 1The abbreviations used are: MMP, matrix metalloproteinase; PKC, protein kinase C; JNK, c-Jun NH2-terminal kinase; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; IKK, IκB kinase; IL-1β, interleukin-1β; PS, pseudosubstrate; TIP, translocation inhibitor peptide; MI, myocardial infarction; MT1, membrane-type 1; PD, PD98059; SP, SP600125. a family of endopeptidases, have the ability to degrade extracellular matrix proteins, and therefore, play a fundamental role in tissue remodeling (1Peterson J.T. Li H. Dillon L. Bryant J.W. Cardiovasc. Res. 2000; 46: 307-315Crossref PubMed Scopus (265) Google Scholar, 2Libby P. Lee R.T. Circulation. 2000; 102: 1874-1876Crossref PubMed Scopus (101) Google Scholar, 3Spinale F.G. Circ. Res. 2002; 90: 520-530Crossref PubMed Scopus (643) Google Scholar, 4Li Y.Y. McTiernan C.F. Feldman A.M. Cardiovasc. Res. 2000; 46: 214-224Crossref PubMed Scopus (384) Google Scholar, 5Creemers E.E. Cleutjens J.P. Smits J.F. Daemen M.J. Circ. Res. 2001; 89: 201-210Crossref PubMed Scopus (534) Google Scholar, 6Coker M.L. Thomas C.V. Clair M.J. Hendrick J.W. Krombach R.S. Galis Z.S. Spinale F.G. Am. J. Physiol. 1998; 274: H1516-H1523PubMed Google Scholar). MMPs are implicated in the remodeling processes of the heart during chronic heart failure and following myocardial infarction (6Coker M.L. Thomas C.V. Clair M.J. Hendrick J.W. Krombach R.S. Galis Z.S. Spinale F.G. Am. J. Physiol. 1998; 274: H1516-H1523PubMed Google Scholar, 7Spinale F.G. Coker M.L. Thomas C.V. Walker J.D. Mukherjee R. Hebbar L. Circ. Res. 1998; 82: 482-495Crossref PubMed Scopus (328) Google Scholar, 8Spinale F.G. Coker M.L. Krombach S.R. Mukherjee R. Hallak H. Houck W.V. Clair M.J. Kribbs S.B. Johnson L.L. Peterson J.T. Zile M.R. Circ. Res. 1999; 85: 364-376Crossref PubMed Scopus (299) Google Scholar, 9Spinale F.G. Coker M.L. Heung L.J. Bond B.R. Gunasinghe H.R. Etoh T. Goldberg A.T. Zellner J.L. Crumbley A.J. Circulation. 2000; 102: 1944-1949Crossref PubMed Scopus (433) Google Scholar, 10Ducharme A. Frantz S. Aikawa M. Rabkin E. Lindsey M. Rohde L.E. Schoen F.J. Kelly R.A. Werb Z. Libby P. Lee R.T. J. Clin. Invest. 2000; 106: 55-62Crossref PubMed Scopus (696) Google Scholar). MMP-2 (gelatinase A) and MMP-9 (gelatinase B), also called type IV collagenases, contain fibronectin-like domains for collagen binding (11Yasumitsu H. Miyazaki K. Umenishi F. Koshikawa N. Umeda M. J. Biochem. (Tokyo). 1992; 111: 74-80Crossref PubMed Scopus (73) Google Scholar) and are known to cleave matrix substrates including gelatin and collagen Type I, IV, V, VII, and X (5Creemers E.E. Cleutjens J.P. Smits J.F. Daemen M.J. Circ. Res. 2001; 89: 201-210Crossref PubMed Scopus (534) Google Scholar). Cardiac fibroblasts in culture constitutively express MMP-2, not MMP-9. Inflammatory cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor-α, increase expression of MMP-2 and -9 (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 13Siwik D.A. Chang D.L. Bond B.R. Colucci W.S. Circ. Res. 2000; 86: 1259-1265Crossref PubMed Scopus (435) Google Scholar). Although both MMP-2 and -9 are activated in the heart during myocardial remodeling, the temporal changes in the expression of these enzymes are different (14Tao Z.Y. Cavasin M.A. Yang F. Liu Y.H. Yang X.P. Life Sci. 2004; 74: 1561-1572Crossref PubMed Scopus (115) Google Scholar). MMP-9 activity increases 1 day after MI, whereas MMP-2 activity starts to increase within 4 days after MI. Furthermore, MMP-9 abundance increases in both ischemic and non-ischemic dilated cardiomyopathy, whereas the abundance of MMP-2 increases only in non-ischemic dilated cardiomyopathy (9Spinale F.G. Coker M.L. Heung L.J. Bond B.R. Gunasinghe H.R. Etoh T. Goldberg A.T. Zellner J.L. Crumbley A.J. Circulation. 2000; 102: 1944-1949Crossref PubMed Scopus (433) Google Scholar). These observations suggest differential regulation of MMP-2 and -9 in the heart. Inflammatory cytokines such as IL-1β and tumor necrosis factor-α are increased during chronic heart failure (15Ukimura A. Terasaki F. Fujioka S. Deguchi H. Kitaura Y. Isomura T. Suma H. J. Cardiovasc. Surg. 2003; 18: S101-S108Google Scholar) and following myocardial infarction (16Ono K. Matsumori A. Shioi T. Furukawa Y. Sasayama S. Circulation. 1998; 98: 149-156Crossref PubMed Scopus (386) Google Scholar, 17Yue P. Massie B.M. Simpson P.C. Long C.S. Am. J. Physiol. 1998; 275: H250-H258PubMed Google Scholar). We have shown that IL-1β activates ERK1/2 and JNKs, not p38 kinase in adult rat cardiac fibroblasts (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). We have also provided evidence that IL-1β activates PKC, specifically PKC-ζ, in cardiac fibroblasts and that activation of PKC plays a critical role in the regulation of MMP-2 and -9 (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). In addition to the activation of MAPKs and PKC, IL-1β has been shown to activate NF-κB in several different cell types (19Newton R. Kuitert L.M. Bergmann M. Adcock I.M. Barnes P.J. Biochem. Biophys. Res. Commun. 1997; 237: 28-32Crossref PubMed Scopus (361) Google Scholar, 20Regnier C.H. Song H.Y. Gao X. Goeddel D.V. Cao Z. Rothe M. Cell. 1997; 90: 373-383Abstract Full Text Full Text PDF PubMed Scopus (1072) Google Scholar, 21Woronicz J.D. Gao X. Cao Z. Rothe M. Goeddel D.V. Science. 1997; 278: 866-869Crossref PubMed Scopus (1068) Google Scholar). The present study was undertaken to investigate the signaling pathways, including MAPKs (ERK1/2 and JNKs), PKC (α, β1,ζ, θ, and ϵ), and NF-κB, involved in the expression and activity of MMP-2 and -9 in response to IL-1β in adult rat cardiac fibroblasts. The data presented here suggest that different isoforms of PKC differentially activate ERK1/2, JNKs, and NF-κB and that activation of ERK1/2, JNKs, and NF-κB differentially modulates the expression and activity of MMP-2 and -9. Antibodies and Reagents—Rabbit polyclonal anti-phospho-ERK1/2, anti-phospho-c-Jun, anti-phospho-IKKα/IKKβ, and mouse monoclonal anti-phospho-IκB-α antibodies were purchased from New England Biolabs (Beverly, MA). Monoclonal anti-phospho-JNK antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), whereas monoclonal anti-MMP-2 and MMP-9 antibodies were purchased from Oncogene Research (Boston, MA). The myristoylated PKC-ζ pseudosubstrate (PKC-ζ-PS) was purchased from BIOSOURCE International (Camarillo, CA). Chelerythrine, Gö6976, PKC-ϵ translocation inhibitor peptide (PKC-ϵ-TIP), myristoylated PKC-θ pseudosubstrate inhibitor (PKC-θ-PS), PD98059, SP600125, and SN50 (peptide inhibitor of NF-κB translocation) were purchased from Calbiochem. Rat Cardiac Fibroblast Culture and Treatment—Adult rat cardiac fibroblasts were isolated from the supernatant of adult rat cardiac myocytes as described (13Siwik D.A. Chang D.L. Bond B.R. Colucci W.S. Circ. Res. 2000; 86: 1259-1265Crossref PubMed Scopus (435) Google Scholar). The cells were grown to confluence and serum-starved for 48 h before use. Cells from the first and second passages were used for all the experiments. The cells were treated with IL-1β (4 ng/ml) for 48 h to measure MMP activity or for 15 min to measure activation of MAPKs, IKKα/β, and IκB-α. To study the role of MAPKs, PKC isoforms, or NF-κB, cells were pretreated with PD98059 (10 μm), SP600125 (10 μm), chelerythrine (5 μm), Gö6976 (5 or 10 nm), PKC-ϵ-TIP (5 μm), PKC-θ-PS inhibitor peptide (50 μg/ml), PKC-ζ-PS (25 μm), or SN50 (100 μg) for 30 min followed by treatment with IL-1β. Western Blot Analyses—Activation of MAPKs (ERK1/2 and JNKs), IKKα/β, and IκB-α was studied using Western blot analyses as described (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). Cells lysates were prepared using lysis buffer (1% Triton X-100, 150 mm NaCl, 10 mm Tris, pH 7.4, 1 mm EDTA, 1 mm EGTA, 0.2 mm phenylmethylsulfonyl fluoride, 0.2 mm sodium orthovanadate, and 0.5% Nonidet P-40), and protein contents were measured using the Bradford assay (Bio-Rad). Equal amounts of protein (30 μg) were subjected to SDS-PAGE, and were to The were with ERK1/2, JNKs, IKKα/β, or IκB-α The were with antibody and as described (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). The protein of was by the with for MMP-2 and -9 were measured in the using monoclonal anti-MMP-2 and activity in was measured as described (13Siwik D.A. Chang D.L. Bond B.R. Colucci W.S. Circ. Res. 2000; 86: 1259-1265Crossref PubMed Scopus (435) Google Scholar). the were for min to cells and and to The was in and protein was by Bradford assay (Bio-Rad). of were with 1 gelatin from as a and the were in Triton for 30 min with followed by a in The were in buffer (50 mm pH mm and in and using and and MMP activity were using a and were using data are as was using the or a of followed by a of were to Inhibition of ERK1/2 and JNKs MMP-9, MMP-2, and of the JNKs, and p38 are known to MMP activity in cell types J. J. Physiol. 2001; PubMed Scopus Google Scholar, X. T. J. 2002; PubMed Scopus Google Scholar). we have shown that IL-1β activates ERK1/2 and JNKs, not in cardiac fibroblasts (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). To activation of ERK1/2 and JNKs plays a role in the regulation of MMP expression and cells were pretreated with PD98059 a inhibitor of ERK1/2 10 or SP600125 a inhibitor of JNKs, 10 for 30 min followed by treatment with IL-1β for 48 of that PD98059 inhibits MMP-9 activity increase IL-1β, IL-1β PD, and B) has no effect on MMP-2 activity increase IL-1β, IL-1β PD, not and Western blot of that IL-1β increases MMP-2 and -9 protein with PD98059 inhibited MMP-9 protein had no effect on MMP-2 Inhibition of JNKs using SP600125 also inhibited MMP-9 activity increase IL-1β, IL-1β SP, and B) had no effect on MMP-2 activity increase IL-1β, IL-1β SP, not and Western blot of that with SP600125 inhibits MMP-9, not MMP-2, protein of JNKs inhibits MMP-9 activity. of cardiac fibroblasts were pretreated with (10 for 30 min followed by with IL-1β (4 ng/ml) for 48 MMP activity and protein in were measured using and Western blot is a the changes in MMP and C MMP-9 and MMP-2 as increase IL-1β. Western blot analyses of using monoclonal anti-MMP-2 and The were with Previously, we have shown that PD98059 and SP600125 specifically IL-1β-stimulated increases in ERK1/2 and JNKs SP600125 from had no effect on IL-1β-stimulated activation of ERK1/2 (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). To the of a of PD98059 and SP600125 in the inhibition of MMP-2 activity and protein cells were pretreated with PD98059 SP600125 followed by treatment with IL-1β for 48 and Western blot analyses that inhibition of both ERK1/2 and JNKs inhibits IL-1β-stimulated MMP-9 activity and protein has no effect on MMP-2 and Inhibition of PKC IL-1β-stimulated of ERK1/2 and we have shown that IL-1β-stimulated activation of PKC plays an role in the expression and activity of MMP-2 and -9 (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). PKC act upstream in the activation of ERK1/2 and JNKs A. Circ. Res. 2001; 89: PubMed Scopus Google Scholar). To cells were pretreated with chelerythrine (5 for 30 min followed by with IL-1β for 15 of cell lysates using antibodies that inhibition of PKC inhibits IL-1β-stimulated activation of ERK1/2 and JNKs as by the phosphorylation of is a not PKC inhibitor and a of PKC that with the and inhibits the T. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). To PKC isoforms involved in the activation of ERK1/2 and JNKs, we used of Gö6976, a inhibitor for and and and 10 inhibited IL-1β-stimulated increases in c-Jun phosphorylation had no effect on ERK1/2 phosphorylation C and PKC-ϵ translocation inhibitor peptide had no effect on IL-1β-stimulated activation of ERK1/2 and JNKs C and PKC pseudosubstrates are and are known to PKC activity by with the in the Science. PubMed Scopus Google Scholar). with PKC-ζ-PS inhibited IL-1β-stimulated activation of ERK1/2 and JNKs by c-Jun whereas PKC-θ-PS a effect C and PKC and of MMP-2 and -9 the role of PKC isoforms on MMP-2 and -9 expression and cells were pretreated with Gö6976 (5 and 10 nm), and PKC-θ-PS for 30 min followed by treatment with IL-1β for 48 of that Gö6976 inhibits IL-1β-stimulated increases in MMP-9 increase IL-1β, IL-1β Gö6976, activity had no effect on MMP-2 activity increase IL-1β, IL-1β Gö6976, not PKC-ϵ-TIP had no effect on IL-1β-stimulated increases in MMP-2 or -9 activity. PKC-ζ-PS and PKC-θ-PS inhibited IL-1β-stimulated activation of MMP-9 increase IL-1β, IL-1β 0.2 IL-1β and increase IL-1β, IL-1β 0.2 IL-1β Western blot of that Gö6976 also MMP-9, not MMP-2, protein with PKC-ζ-PS and PKC-θ-PS inhibited IL-1β-stimulated increases in MMP-9 and protein PKC-ζ-PS PKC-θ-PS also inhibits the protein of MMP-2. PKC-ζ and of NF-κB, and Inhibition of NF-κB IL-1β-stimulated and of MMP-2 cytokines are known to activate NF-κB in different cell types (19Newton R. Kuitert L.M. Bergmann M. Adcock I.M. Barnes P.J. Biochem. Biophys. Res. Commun. 1997; 237: 28-32Crossref PubMed Scopus (361) Google Scholar, 20Regnier C.H. Song H.Y. Gao X. Goeddel D.V. Cao Z. Rothe M. Cell. 1997; 90: 373-383Abstract Full Text Full Text PDF PubMed Scopus (1072) Google Scholar, 21Woronicz J.D. Gao X. Cao Z. Rothe M. Goeddel D.V. Science. 1997; 278: 866-869Crossref PubMed Scopus (1068) Google Scholar). To IL-1β activates NF-κB and the role of PKC in the activation of NF-κB, we studied phosphorylation of IKKα/β and IκB-α. Western blot that IL-1β increases phosphorylation of both IKKα/β and IκB-α within 15 min of activation of NF-κB with Gö6976 and PKC-ϵ-TIP to IL-1β-stimulated increases in IKKα/β and IκB-α PKC-ζ-PS inhibited IL-1β-stimulated increases in IKKα/β and IκB-α whereas PKC-θ-PS only a effect and To activation of NF-κB is MAPKs, cells were pretreated with PD98059 and SP600125. of cells with PD98059 and SP600125 or in had no effect on IL-1β-stimulated increases in IKKα/β and IκB-α phosphorylation C and To the role of NF-κB in the regulation of IL-1β-stimulated increases in MMP-2 and -9 activity and protein cells were pretreated with SN50, an inhibitor of NF-κB. of that SN50 inhibits IL-1β-stimulated increases in MMP-9 increase IL-1β, IL-1β SN50, and B) and MMP-2 activity increase IL-1β, IL-1β SN50, and Western in MMP-9 and protein IL-1β activates ERK1/2 and JNKs, not p38 in adult rat cardiac fibroblasts (18Xie Z. Singh M. Singh K. J. Cell. Physiol. 2004; 198: 399-407Crossref PubMed Scopus (72) Google Scholar). we that IL-1β activates PKC and that activation of PKC plays a critical role in the regulation of MMP-2 and -9 expression and activity (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). The of study are that 1) activation of ERK1/2 and JNKs plays a critical role in the regulation of MMP-9, not MMP-2, expression and activity; 2) PKC-α/β1 act upstream of JNKs, not ERK1/2; 3) PKC-ζ and -θ, not PKC-ϵ, act upstream of ERK1/2, JNKs, and NF-κB; and 4) activation of NF-κB stimulates expression and activity of MMP-2 and -9. MMPs are to play a critical role in myocardial remodeling following A. Frantz S. Aikawa M. Rabkin E. Lindsey M. Rohde L.E. Schoen F.J. Kelly R.A. Werb Z. Libby P. Lee R.T. J. Clin. Invest. 2000; 106: 55-62Crossref PubMed Scopus (696) Google Scholar). IL-1β, increased in the heart following MI, increases expression and activity of MMP-2 and -9 in adult rat cardiac fibroblasts (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). we show that inhibition of ERK1/2 and JNKs or in inhibits IL-1β-stimulated increases in MMP-9, not MMP-2, protein and activity. These data suggest the of in the regulation of both MMP-2 and -9 expression and activity. These are with the observations that MMPs MMP-9, and contain or in whereas the of MMPs and not contain an Matrix Biol. 1997; PubMed Scopus Google Scholar, J. J. 1999; PubMed Scopus Google Scholar). The is by of different of and protein family The expression of and is the activation of ERK1/2 and JNKs, is to that activation of ERK1/2 pathway is shown to play a critical role in the regulation of MMP-2 activity in cells H. S. T. K. N. M. Res. 2000; PubMed Scopus Google Scholar). The of of and that are involved in the regulation of both MMP-2 and -9 is by data that inhibition of PKC using chelerythrine inhibits IL-1β-stimulated increases in MMP-2 and -9 expression and (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). MMP-9 has a binding for which is by PKC J. J. 1999; PubMed Scopus Google Scholar, J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The MMP-2 and In activation of PKC and protein kinase activated and MMP-2 expression J. J. 1999; PubMed Scopus Google Scholar, M. R. M. Cell. Full Text PDF PubMed Scopus Google Scholar). PKC activation is to for the of MMP expression in response to cytokines, such as IL-1β and tumor necrosis factor-α in fibroblasts and tumor cell M. A.M. J.L. 1992; Google Scholar, Yang Y. J. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, S. J.W. Bond M. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, J.F. M. Liu Biochem. Biophys. Res. Commun. 2002; PubMed Scopus Google Scholar). PKC a family of and plays an role in the regulation of The of the PKC family are to and A. Circ. Res. 2001; 89: PubMed Scopus Google Scholar, K. J. Cell. 2001; Full Text PDF PubMed Scopus Google Scholar, K. Circ. Res. 2000; 86: PubMed Scopus Google Scholar). In using PKC we show that PKC-α/β1 play a critical role in the regulation of MMP-9 expression and whereas activation of PKC-ζ and PKC-θ plays a critical role in the regulation of expression and activity of MMP-2 and -9. The data presented here suggest that different isoforms of PKC differentially the expression and activity of MMPs in cardiac fibroblasts in response to IL-1β. isoforms of PKC are known to signaling pathways A. Circ. Res. 2001; 89: PubMed Scopus Google Scholar). In cardiac activation of ERK1/2 is PKC-ϵ, whereas activated JNKs and p38 kinase J.L. A.M. Circ. Res. 2001; 89: PubMed Scopus Google Scholar, J.L. A. R. A.M. Am. J. Physiol. 2001; Google Scholar). The data presented here suggest that and act upstream of JNKs, whereas PKC-ζ and act upstream of both ERK1/2 and of ERK1/2 JNKs The differential of PKC isoforms on the regulation of activity in different cell types in activation of different isoforms of PKC and IL-1β has been shown to activate ERK1/2, JNKs, and p38 kinase pathways in J.F. J.D. Am. J. Physiol. 2002; PubMed Scopus Google Scholar). of study is that PKC-ζ and -θ, not or act upstream in the activation of NF-κB signaling pathway and that inhibition of NF-κB inhibits IL-1β-stimulated increases in MMP and expression and activity. activation of NF-κB was studied using increased phosphorylation of IKKα/β and IκB-α kinase as an phosphorylation and activation of IKKα/β increases phosphorylation of IκB-α. the IκB-α protein is by the NF-κB to the M. E. M. 1997; PubMed Scopus Google Scholar). Inhibition of ERK1/2 and JNKs to IL-1β-stimulated increases in phosphorylation of IKKα/β and activation of NF-κB of The data presented here suggest both PKC-ζ and are involved in the activation of NF-κB. However, the effect of PKC-ζ These data are with the of J. H. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar) in which PKC-ζ has been shown to for the activity of NF-κB in NF-κB has been to play a role in the regulation of MMP expression E. F. A. Y. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, H. M. W.L. J. Sci. 2001; Google Scholar). The of the MMP-9 has a NF-κB J. J. 1999; PubMed Scopus Google Scholar). NF-κB activity is shown to for the of MMP-9 in cells in response to cytokines H. M. Google Scholar, J.D. M. M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). Inhibition of NF-κB activation using SN50 inhibits MMP-9 expression and activity by IL-1β in adult cardiac fibroblasts. However, data that NF-κB activity plays an role in the regulation of IL-1β-stimulated increases in MMP-2 in cardiac fibroblasts are no has been in MMP-2 J. J. 1999; PubMed Scopus Google Scholar). of MMP-2 is by membrane-type 1 MMP in with tissue of MMPs H. S. S. J. 1999; PubMed Scopus Google Scholar). has an in H. M. W.L. J. Sci. 2001; Google Scholar). is that IL-1β-stimulated activation of NF-κB increases MMP-2 activity the increased expression of is also that NF-κB modulates MMP-2 expression and activity with that MMP-2 The is by data that inhibition of NF-κB also inhibits protein as well as activity of MMP-2. The data presented here differential regulation of MMP-2 and -9 expression and activity in adult rat cardiac fibroblasts. PKC-α/β1 activates JNKs, to increased protein and activity of MMP-9, whereas PKC-θ and PKC-ζ activate JNKs, ERK1/2, and NF-κB, in increased protein and activity of both MMPs IL-1β-stimulated increases in MMP-9 expression and activity PKC-ζ, ERK1/2, JNKs, and NF-κB signaling whereas IL-1β-stimulated increases in MMP-2 expression and activity are PKC-ζ, and NF-κB Although these observations are in activation of PKC, NF-κB, and has been in the of after J. K. Res. 2002; PubMed Scopus Google Scholar, S. H. P. J. Cardiovasc. Res. 2003; PubMed Scopus Google Scholar). NF-κB and are also activated in heart failure to ischemic and dilated cardiomyopathy S. H. P. J. Cardiovasc. Res. 2003; PubMed Scopus Google Scholar). We have increased phosphorylation of PKC-ζ in after (12Xie Z. Singh M. Siwik D.A. Joyner W.L. Singh K. J. Biol. Chem. 2003; 278: 48546-48552Abstract Full Text Full Text PDF PubMed Scopus (72) Google whereas have shown increased expression of and not PKC-ϵ, in rat after J. K. Res. 2002; PubMed Scopus Google Scholar). the that activation of these signaling pathways to remodeling of the heart by differentially the expression and activity of MMP-2 and -9. of the regulation of MMP is for the of for the of matrix and remodeling during chronic heart failure and after MI.

References

36